Smartphone App for monitoring Asthma in children and adolescents

ConclusionsTechnology has the capability of transforming the use of patient-reported outcomes. Describing all the development phases of a mobile health application for monitoring children and adolescents with asthma may increase the knowledge on how to design applications for young patients.
Source: Quality of Life Research - Category: Health Management Source Type: research

Related Links:

From ACAAI 2021, Dr Sandhya Khurana reports on advances in asthma, including novel biologic therapies, burden of corticosteroid use, and racial differences in late effects of COVID-19.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news
Conditions:   Asthma;   Asthma in Children Intervention:   Sponsors:   Columbia University;   National Institute of Nursing Research (NINR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Asthma Interventions:   Dietary Supplement: CARDIO®;   Dietary Supplement: Placebo Sponsors:   Hofseth Biocare ASA;   Møre og Romsdal Hospital Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Definitely have a knowledge gap here, but figured brushing up here would be useful since we end up with boarding ICU vented patients. Usually I'll set the tidal volume to 400-500cc, RR 15-18, higher PEEP for ARDS/CHFer types, minimal for asthma patients, and let the ICU handle the rest. Has worked well for me so far. Hoping @sylvanthus and some of the CCM folks can jump in here. What kind of specific vent settings do you guys prefer to use for common situations, such as CHF, ARDS... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Emergency Medicine Source Type: forums
CONCLUSION: Our findings demonstrated pre-existing asthma was significantly associated with a reduced risk for COVID-19 mortality in the United States.PMID:34844871 | DOI:10.1016/j.intimp.2021.108390
Source: International Immunopharmacology - Category: Allergy & Immunology Authors: Source Type: research
Expert Rev Respir Med. 2021 Nov 30. doi: 10.1080/17476348.2021.2011222. Online ahead of print.ABSTRACTINTRODUCTION: Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research
Black children in the US are twice as likely as white children to experience asthma morbidity.1 Inhaled therapy is a cornerstone of asthma care to reduce morbidity.2 However, inhaler technique is poor among children, particularly among Black children, thereby accentuating disparities.3,4
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
Source: Journal of Asthma and Allergy - Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research
Condition:   Asthma Intervention:   Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: Journal of Asthma and Allergy - Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research
More News: Asthma | Child Development | Children | Health Management | Pediatrics | Study